Human cytomegalovirus (HCMV) is a common cause of congenital infection leading to birth defects and a leading cause of serious illness in patients with immunodeficiencies. Studies in this laboratory have focused on a molecular analysis of the immune response to glycoprotein B (gB) of HCMV. This protein has been shown to elicit B cell, helper T cell (Th), and cytotoxic T cell responses, suggesting that it may be useful as a subunit HCMV vaccine. However, previous studies showed that although peripheral blood mononuclear cells (PBMC) from all HCMV-seropositive donors proliferate in response to stimulation with whole HCMV, not all donors respond to purified recombinant gB. In the present study, PBMC from HCMVseropositive donors homozygous for HLA-DR were tested for proliferative responses to whole HCMV and to purified gB expressed in vaccinia virus. PBMC from all donors proliferated in response to HCMV, but those from multiple donors expressing the HLA-DR3Dw3 and -DR4Dw4 specificities, and single donors expressing the -DR15Dw2, -DR13Dwl9 and-DR14Dw9 specificities, failed to respond to gB. These results suggested a possible HLA-DR association with low proliferative responses to gB. In further studies, PBMC from donors expressing both putative gB-high responder and low responder HLA-DR alleles were stimulated multiple times with gB to generate gB-specific T cell lines. These cells were then tested for proliferative responses to gB presented by irradiated PBMC sharing only one DR allele with the responder cells. Cells from the gB-specific lines proliferated only when antigen was presented in the context of a responder DR allele but not when presented in the context of a low responder DR allele. Analysis of immune sera revealed that those from donors with PBMC proliferative responses always contained antibodies reactive with B cell epitopes on both the Nterminal gp93 and C-terminal gp55 portions of gB. In contrast, many of the sera from donors with low gBspecific proliferative responses had gp55-specific antibodies but lacked antibodies to gp93. These results suggest that immunogenetic differences in T h responsiveness to gB may lead to lack of antigen-specific help for antibody responses to gp93 in some cases. The prevalence of these low responder HLA alleles in the population, and the central importance of the T cell response to the generation of antibodies suggest that native gB alone may not be an attractive candidate for an HCMV subunit vaccine.
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Introduction
Infection with human cytomegalovirus (HCMV) stimulates both humoral and cellular immune responses in man (Rasmussen, 1990; Gehrz, 1991) . Antibodies reactive with regulatory and structural viral proteins can be detected in convalescent sera (Pereira et al., 1982a; Landini et al., 1985 ; Hayes et al., 1987; Gold et al., 1988 ; Kari & Gehrz, 1990) . In addition, a number of HCMV proteins have been shown to elicit cytotoxic T cell (To) responses (Charpentier et al., 1986; Borysiewiez et al., 1988; Liu et al., 1991a; Riddell et al., 1991) . These effector functions develop only in the presence of a strong helper T cell (T 0 response which results in the production of various cytokines which are essential to the differentiation of B cells and To. The T h response to HCMV has been shown to be stimulated primarily by envelope glycoproteins forming the glycoprotein complexes gcI and gclI (Liu et al., 1988a, b) , the matrixtegument protein pp65 (Forman et al., 1985; Liu et al., 1988b) , an early 72K protein (Rodgers et al., 1987) and the major immediate-early protein (Alp et al., 1991) .
One focus of this and other laboratories has been the characterization of humoral and cell-mediated immune 0001-1916 0001- © 1994 responses to the envelope glycoprotein B (gB), which is a component of glycoprotein complex gcI (Gretch et al., 1988; Kari et al., 1990) . Our laboratory and others have derived murine monoclonal antibodies (MAbs) which react with either the N-terminal gp93 subunit or the Cterminal gp55 subunit of gB (Pereira et al., 1982b; Britt, 1984; Rasmussen et al., 1985; Kari et al., 1986 Kari et al., , 1990b Lussenhop et al., 1988) and human antibodies to both proteins have been detected in sera from HCMVseropositive donors (Kari & Gehrz, 1990) . T~ lines generated in response to HCMV-infected cells have specificity for gB (Liu et al., 1991a) . In addition, numerous T h clones which are specific for gB have been isolated in our laboratory (Liu et al., 1993) . We have previously reported that the majority of HCMV-specific T h clones are restricted by HLA-DR molecules (Gehrz et al., 1987) . We have now analysed a large number of clones which are specific for gB to show that DR is immunodominant in the T h response to this glycoprotein (P. R. Donahue et al., unpublished) . In addition, the epitopes that stimulate many of these clones have been mapped (Liu et al., 1993) . Each DR allele associates with a limited number of epitopes (1 to 3) on gB, suggesting the possibility that certain DR alleles might not associate productively with any epitopes of gB.
In this paper we demonstrate that the magnitude of the in vitro T cell proliferative response to gB is determined by the HLA-DR haplotype of the donor. In addition, we report that the absence of antibodies to the N-terminal gp93 subunit of gB correlates with the lack of an in vitro proliferative response to gB. The implications of these results for development of a subunit vaccine for HCMV are discussed.
Methods
HCMV antigen preparation. HCMV antigen was prepared by purification of Towne strain HCMV virions and dense bodies as previously described (Gehrz et al., 1980) .
Gl.veoproteins expressed #z vaccinia virus.
Recombinant vaccinia viruses containing the entire HCMV gB gene (vac-gB) or the nucleotides coding for the N-terminal 163 amino acids (aa) of gB (vac-gBm163) were generated by Tn5 transposon-induced C-terminal deletion as previously described . Recombinant glycoproteins gB and gBm 163 were immunoaffinity-purified from lysates of HuTK cells infected with the corresponding vaccinia virus recombinants using a biotinylated MAb, 3C2 (which reacts with an epitope in the region ofaa 50 to 77), according to methods previously described (Gretch et al., 1987) . Recombinant proteins of the appropriate molecular masses were identified by Western blot analysis (data not shown).
Peripheral blood mononuclear cells (PBMC) and gB-specific T cell lines. PBMC were obtained from heparinized peripheral blood of normal adult donors expressing known HLA haplotypes; the cells were cryopreserved in 10% DMSO in liquid nitrogen prior to use as described previously (Liu et al., 1988b) . gB-specific T cell lines were generated by initial stimulation of PBMC at 1 x 108/ml with immunoaffinity-purified recombinant gB at the optimal stimulatory concentration in RPMI 1640 (Celox) containing 15 % pooled human serum from HCMV-seronegative normal male donors. After 7 days, Lympbocult T (Biotest) was added as a source of interleukin (IL)-2 to a final concentration of 15%. On days 14 and 21 the cells were restimulated with recombinant gB antigen in the presence of autologous irradiated PBMC, as antigen-presenting cells (APC) and Lymphocult T as described previously for HCMV-specific T cell lines (Liu et al., 1988b ). These lines were tested for the expression of the T cell marker CD3 by flow cytometry and were all greater than 90 % CD3 + (data not shown).
Antigen-presenth~g cells. Autologous or allogeneic PBMC expressing shared or disparate HLA class II alleles with those of the T cell donor were irradiated with 5000 rad prior to use as APC.
Donor HLA haplotypes. The HLA class II haplotypes of donors used as a source of PBMC for proliferation assays, T cell lines and APCs were determined in the HLA Typing Laboratory at the University of Minnesota using allotype-specific antisera and mixed lymphocyte culture responses to homozygous typing cells of defined D-region specificity.
Lymphocyte proliferation assay. PBMC proliferation assays were performed by stimulation of 105 PBMC/well in 96-well round bottom microtitre plates for 7 days with optimal concentrations of HCMV antigen or recombinant gB, or in culture medium alone as a negative control, as previously reported (Liu et al., 1988 b) . Proliferation assays of gB-specific T cell lines were performed by incubating 2 x 104 T cells for 72 h with 105 irradiated autologous or allogeneic PBMC as APC in the presence or absence (negative control) of antigen. Radiolabelling, harvesting and counting were the same as for PBMC. Results are expressed as the mean counts per minute (c.p.m.) from triplicate wells. The S.E.M. was typically < 10% of the mean proliferative response. Positive responses were considered to be those greater than five times the response of negative controls, although antigen-specific responses were typically > 10-fold higher than those of the controls.
Antibody detection. HCMV antibody titres were determined as described previously (Gehrz et aI., 1980) . Complement fixation and indirect immunofluorescence titres of < 4 to < 10, respectively, were considered negative. Antibody responses to gB were determined by Western blot analysis as described previously (Lussenhop et al., 1988) ; antigens used were gB glycoproteins containing the entire gB sequence (aa 1 to 907) or the N-terminal 163 amino acids (aa 1 to 163) expressed in recombinant vaccinia viruses. The N-terminal 163 amino acid glycopeptide contains the major complement-independent neutralizing B cell epitope on gp93 (aa 68 to 77) which has been reported previously (Meyer et al., 1992; Ohlin et al., 1993) and which is recognized by our murine gp93-specific MAbs, 3C2 and 9F9. Positive and negative responses in immunoblots were determined by the presence or absence of a band comigrating with the positive bands formed by reaction of MAbs 3C2 and 9F9 with the antigens used.
Results

Analysis of proliferative responses by PBMC from HLA-DR homozygous donors
Previous studies from this laboratory demonstrated that the T cell proliferative response to HCMV is primarily mediated by CD4 + T cells which are restricted by HLA-DR (Gehrz et al., 1987) . In earlier studies (Liu et at., 1988a; Gehrz et al., 1991) , we found that PBMC from some HCMV-seropositive donors exhibited high pro- * HLA haplotype analysis was performed using allotype-specific antisera and mixed lymphocyte culture responses to homozygous typing cells of defined HLA specificity.
t Proliferation assays were set up using 1 x l0 s PBMC and HCMV antigen or purified recombinant gB. The cells were cultured for 7 days, and [3H]thymidine was included in the cultures during the last 16 h. Results are expressed as mean c.p.m, of triplicate wells; positive proliferative responses are underlined. PBMC from some donors (M J-4, AL-10, VG-19, SSEK) were assayed only once. PBMC from other donors were assayed twice (MS~7, MMC-3, LS-3, DH-3) or three times (KKL-2, LL-4, ART-7) with comparable results.
:~ Sucrose gradient-purified Towne strain HCMV was used at 1 lag/ml; affinity-purified recombinant gB expressed in vaccinia virus was used at multiple concentrations; the maximum response is reported.
liferative responses to both whole HCMV antigen and purified gB, whereas other donors responded to whole HCMV but gave a low proliferative response after stimulation with gB. These donors were all heterozygous for HLA-DR. Therefore, to assess the possible role of HLA-DR in determining the ability to respond to gB, PBMC from HCMV-seropositive donors who are homozygous at the HLA-DR locus were tested in a proliferation assay.
As seen in Table 1 , PBMC from one donor expressing the DR4Dwl0 allele, one donor expressing the DR7Dw7 allele and one of two donors expressing the DR15Dw2 allele exhibited high proliferative responses to stimulation with both whole HCMV antigen and purified gB. These data suggest that these DR alleles can associate with epitopes on gB and are therefore gB-high responder alleles. Proliferative responses of PBMC from three donors expressing DR3Dw3, two donors expressing DR4Dw4, one donor expressing DR13Dwl9 and one donor expressing DR14Dw9 were positive when the antigen was whole HCMV, but clearly negative when the antigen was gB. These data suggest that certain DR alleles may not recognize any T h epitopes on gB and are therefore gB-low responder alleles.
Analysis of proliferative responses by gB-specific T cell lines
The possibility always exists that lack of a PBMC proliferative response to gB is due to a lack of crossreactivity of T cells induced by wild HCMV strains with the Towne strain gB sequence rather than gB nonresponsiveness primarily determined by expression of certain DR alleles. In fact, we have determined that even among the limited number of T cell epitopes on gB that have been defined to date, there is sequence variation among HCMV strains which affects T cell responsiveness (Liu et al., 1991 b) . Therefore, we wished to assess the response to gB by PBMC from additional donors expressing putative low responder alleles. We chose to focus on DR3Dw3 and DR4Dw4. As we did not have access to additional HCMV-seropositive individuals who were homozygous for DR3Dw3 or DR4Dw4, we used a different approach to confirm the correlation between these HLA-DR alleles and a low proliferative response to gB. Donors were selected who were heterozygous for HLA-DR and expressed one of the putative gB-low responder alleles and one of the gB-high responder alleles. T cell lines specific for gB were generated from these donors by incubation of their PBMC with recombinant gB, followed by restimulation an additional one or two times with purified gB in the presence of irradiated autologous PBMC as APC and conditioned medium containing IL-2. These cells were greater than 90 % CD3 + by flow cytometry analysis (data not shown). The gB-specific T cell lines were then tested for their proliferative responses to gB in the presence of a panel of APC, including those which were matched for only one of the HLA-DR alleles expressed by the donor of the responding cells. Fig. 1 shows the results of studies with two lines from donors expressing the putative gB-low responder DR4Dw4 allele and a gB-high responder allele, either DR4Dwl0 or DR7Dw7. The gB-specific T cells from donor CG (Fig. l a) proliferate well in response to antigen in the presence of autologous APC or APC from two donors sharing the DR4Dwl0 allele with the responding cells. However, APC from three donors sharing only DR4Dw4 with the responder fail to support any proliferation in response to gB or HCMV. Also, unmatched APC do not present antigen to the T cell line. Similarly, the gB-specific T cells from donor VM (Fig.  1 b) Fig. 1 . Responses by gB-specific T cell lines from donors expressing DR4Dw4. T cell lines with specificity for gB were generated by repeated stimulation of PBMC from donors CG (a) and VM (b) with purified recombinant gB in the presence of autologous irradiated PBMC as APC and a source of IL-2, as described in Methods. Proliferation assays were set up using 2 x 104 T cells, 10 ~ irradiated PBMC from the donors indicated as APC, and either HCMV at 1 gg/ml or recombinant gB at several concentrations; the optimal response to gB is reported here. Cells were cultured for 3 days, with (Table 1) , support the conclusion that D R 4 D w 4 is a gB-low responder allele. Fig. 2 shows the results of studies with two gB-specific lines from donors expressing D R 3 D w 3 and D R 7 D w 7 , which are putative gB-low responder and high responder alleles, respectively. As seen in Fig. 2(a) , gB-specific T cells from d o n o r D C proliferated in response to antigen presented by autologous A P C and A P C expressing D R 7 D w 7 , but did not proliferate in response to antigen presented by A P C expressing D R 3 D w 3 or by A P C Fig. 2 . Responses by gB-specific T cell lines from donors expressing DR3Dw3. T cell lines with specificity for gB were generated from donors DC (a) and JPH (b), and analysed for proliferative responses to HCMV and recombinant gB as described in Fig. 1 and Methods.
unmatched at DR. The gB-specific T cells from the second donor, J P H (Fig. 2b) , also gave the strongest proliferative response when A P C expressed D R 7 D w 7 , although autologous A P C did not stimulate well in this experiment. A P C from two donors sharing the D R 3 D w 3 allele with the responder and from two unmatched donors failed to support a proliferative response to gB or H C M V . The results in Fig. 2 , together with the results with three donors h o m o z y g o u s for D R 3 D w 3 (Table 1) , support the conclusion that D R 3 D w 3 is a gB-low responder allele. The results in Fig. 1 and 2 also confirm that D R 4 D w l 0 and D R 7 D w 7 are gB-high responder alleles, as was suggested by the data in Table 1 . In addition, these results support previous studies from this laboratory (Gehrz et al., 1987) showing that the DR-restricted response to H C M V is immunodominant. We anticipated that we might see at least a low level o f proliferation stimulated by unmatched A P C or A P C matched for the low responder D R allele, since some of these A P C donors are matched with the responder for DQ. Also, D P polymorphism is more limited than that of D R or DQ, so it is likely that some of these A P C donors were matched with the responder for DP. However, as noted above, only matching for the high responder D R allele led to significant proliferation in response to gB. antisera and mixed lymphocyte culture responses to homozygous typing cells of defined HLA specificity. ~ Antibody responses to whole HCMV were assessed by complement fixation and indirect immunofluorescence. Antibody responses to gB were determined by Western blot analysis; antigens used were gB glycoproteins containing the entire gB sequence (aa 1 to 907) or the Nterminal 163 amino acids (aa 1 to 163) expressed in recombinant vaccinia viruses. Positive and negative responses in immunoblots were determined by the presence or absence of a band comigrating with the positive bands formed by reaction of our murine gp93-specific MAbs 3C2 and 9F9 with the antigens used.
:~ Proliferation assays were set up using 1 x 105 PBMC and HCMV antigen or purified recombinant gB. The cells were cultured for 7 days, and [3Hlthymidine was included in the cultures during the last 16 h.
Mean c.p.m, of triplicate wells was determined. Results were scored as positive when mean c.p.m, in the presence of antigen was > fivefold the mean c.p.m, in the absence of antigen. Sucrose gradient-purified Towne strain HCMV was used at 1 gg/ml; affinity-purified recombinant gB was used at multiple concentrations.
Analysis of antibody and proliferative responses to gB by HLA-DR heterozygous and homozygous donors
Because the T cell proliferative response is dependent upon T h, and because the T h response is central to the development of both humoral and cytotoxic responses, we reasoned that the effect of the HLA-DR phenotype on the gB-specific T cell proliferative response might secondarily influence the specificity of the B cell response to gB. To test this possibility, antibody and proliferative responses of a panel of HLA-typed HCMV-seropositive donors were determined.
As seen in Table 2 , sera from five HCMV-seropositive donors did not contain detectable levels of antibodies reactive with gp93. Of particular interest, we noted that all of the five donors who lacked gp93-specific antibodies also lacked PBMC proliferative responses to gB. These results suggest that the absence of gB-specific Th which can provide cognate help to B cells could lead to failure to generate gp93-specific antibodies. The two homozygous donors who lacked both gp93-specific antibodies and PBMC proliferative responses to gB expressed DR3Dw3 and DR4Dw4, the two low responder DR alleles defined in this paper.
Discussion
Previous studies from this laboratory have suggested that the T~ response to gB of HCMV is limited to a small number of epitopes for each restricting class II allele (Liu et al., 1993) . This observation led to the hypothesis that certain alleles would fail to associate with any epitope on gB, resulting in a low T cell proliferative response to gB. We have demonstrated in this paper that this is indeed the case. First, PBMC from HLA-DR homozygous donors expressing certain DR alleles exhibited high proliferative responses to gB, whereas those from donors expressing other alleles had low responses to gB. Analysis of polyclonal gB-specific T cell lines from HLA-DR heterozygous donors confirmed that the two alleles chosen for study, DR4Dw4 and DR3Dw3, were in fact associated with a low proliferative response to gB. The data also support the conclusion that DR4Dwl0 and DRTDw7 are gB-responder alleles.
In our studies using HLA-DR homozygous donors, we noted that the gB-specific response by PBMC from one of the DR15Dw2 homozygous donors (KKL-2) was low, whereas the gB response of a second donor (MS-7) was high. One possible explanation for this observation is that the DR15Dw2-restricted T h epitope in Towne strain HCMV may not be conserved in all wild strains. Consequently, the infecting strain that elicited the HCMV-specific T cell response in KKL-2 may either not contain an epitope on gB which associates with DR15Dw2, or the DR15Dw2-restricted T cells elicited by this strain may not cross-react with the Towne DR15Dw2-restricted gB epitope. We have previously shown that sequence variation in gB can occur in defined T cell epitopes, and that this variation affects T cell responses (Liu et al., 1991b) .
Class II-restricted T h can have a direct role in host defence against persistent viruses such as HCMV by production of antiviral cytokines such as interferon gamma and, in some cases, by cell-mediated cytotoxicity. In addition, T h provide help to specific B and HLA class I-restricted T c precursors. Thus, deficits in the T h response to gB could have larger effects on the immune response to gB. In this paper, we examined the possible consequences of low T h responses to gB on the gBspecific antibody response. We found that five of 19 HCMV-seropositive donors tested did not have antibodies specific for epitopes on the gp93 portion of the gB polypeptide. These five donors did have antibodies that reacted with the whole gB complex, presumably with specificity for gp55. The failure to detect gp93-specific antibodies in these five is unlikely to be due to lack of cross-reactivity of antibodies in our test sera with the gB(aa 1 to 163) polypeptide derived from the Towne strain which was used in our Western blot experiments, because we have previously shown that gp93-specific MAbs react with all HCMV strains (Gehrz et al., 1992) . Furthermore, sequence analysis of gB from a large number of HCMV strains has shown that the major neutralizing B cell epitope on gp93 in the region of aa 68 to 77 is highly conserved (Chou, 1992) . Interestingly, the two DR homozygous donors who lacked gp93-specific antibodies expressed HLA-DR alleles which were consistent with a gB-low responder phenotype and in fact exhibited low proliferative responses to gB. The remaining three donors also expressed at least one allele which our observations suggest may be a low responder allele for gB (DR2Dw21, DR4Dwl3 and DR4Dwl5, unpublished observations; DR3Dw3, this paper) and did not express DR alleles which we have shown to be associated with gB responsiveness.
Our results suggest that the absence of gB-specific T~ that can provide antigen-specific help to B cells could lead to a failure to generate gp93-specific antibodies in some cases. The ability of the gp93 antibody-negative donors to generate gp55-specific antibodies suggests that the gp55 antibody response somehow bypasses the need for antigen-specific cognate help or, alternatively, there may be a DQ-or DP-restricted T h cell response to gB that contributes little to the proliferative response but is sufficient to provide T cell help. These explanations may also account for the fact that sera from two donors whose PBMC do not proliferate in response to gB do contain gp93-specific antibodies.
All routine and human MAbs that react with the major antigenic site on gp93 which have been obtained to date neutralize HCMV in the absence of complement (Masuho et al., 1987; Meyer et al., 1992; Ohlin et al., 1993) , whereas most gp55-specific MAbs require complement for neutralization (Pereira et al., 1984; Britt, 1984; Rasmussen et al., 1985; Karl et al., 1986; Banks et at., 1989; Ohlin et al., 1993) . Human immune sera also contain gB-specific neutralizing antibodies, including a significant proportion which reacts with epitope(s) on the N-terminal portion of the gB polypeptide (Britt et al., 1990; . This suggests that antigenic sites on gp93 recognized by complement-independent antibodies may reside in functional domains involved in virus attachment or fusion with the plasma membrane. Consequently, antibodies to gp93 may be particularly important in limiting HCMV infection and cell-to-cell spread.
We conclude from these studies that certain HLA-DR alleles are associated with a low gB-specific T cell proliferative response, suggesting a diminished Th response. This low T cell response can be associated with a deficiency in the antibody response to gp93. During natural infection with HCMV, HLA-related deficits in the T h response to gB may not compromise the host since compensatory T h responses to other viral proteins are likely to be sufficient to provide help for protective neutralizing antibody and To responses to gB and other HCMV proteins. However, HLA regulation of the T h response to gB, and probably other HCMV proteins as well, may present a major obstacle to development of a subunit vaccine consisting of a single recombinant viral protein. Individuals expressing two low responder HLA haplotypes would not be expected to develop T h responses to the vaccine protein, nor would compensatory T~ responses to other viral proteins be elicited to provide cognate help for B cells and T c specific for the vaccine proteins. Consequently, a substantial portion of the vaccinated population would still be susceptible to natural infection with HCMV.
